National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

    Search  
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
Related Pages
Coping with Cancer
Managing side effects and complications caused by cancer and its treatment.

Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.
Supportive Care Trial Results
6.  Palliative Radiation Extends Survival for Elderly Patients with Glioblastoma
(Posted: 04/30/2007) - Elderly patients with glioblastoma benefit from palliative radiation therapy, which provides significantly increased survival with no detriment to quality of life, according to the April 12, 2007, New England Journal of Medicine.

7.  Longer Course of Radiation Provides Better Palliation in Advanced NSCLC
(Posted: 01/30/2007) - In patients with advanced non-small cell lung cancer and a poor outlook, a longer, less intense course of radiation treatment improved patients' life expectancy and was cost-effective, according to the Dec. 20, 2006, Journal of the National Cancer Institute.

8.  Zoledronic Acid Prevents Bone Loss During Estrogen-Suppression Treatment of Breast Cancer
(Posted: 01/09/2007, Reviewed: 09/16/2008) - Zoledronic acid can prevent treatment-induced bone loss in premenopausal women undergoing total estrogen suppression after surgery for hormone-responsive breast cancer, according to an article published online Jan. 3, 2007, in the Journal of Clinical Oncology.

9.  Palifermin Reduces Chemotherapy-Induced Mouth Sores in Colorectal Cancer Patients
(Posted: 12/13/2006) - The drug palifermin reduced the frequency and severity of mouth sores caused by the chemotherapy drug fluorouracil in patients with advanced colorectal cancer, according to the Nov. 20, 2006, Journal of Clinical Oncology.

10.  Dexamethasone Helps Control Radiation-Induced Nausea and Vomiting
(Posted: 08/28/2006) - Addition of the steroid drug dexamethasone to standard supportive care for patients undergoing radiation therapy to the stomach area provided significantly better complete control of vomiting, lower levels of nausea, and less use of emergency anti-nausea medications during the course of treatment, according to the July 20, 2006, issue of the Journal of Clinical Oncology.
< Previous  1 2 3 4 5   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov